We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Outlines Its Strategy for Data Modernization
The FDA has laid out its plan to modernize the way it interacts with data to inform regulatory decisions like drug reviews, unveiling a three-component Data Modernization Action Plan (DMAP) on Wednesday that will begin bringing its data strategies up to date.